Mech-Mind Robotics Lists in Hong Kong
Sep 01, 2026
Robotics
Insilico Medicine Joins HKEX Tech 100 Index
September 03, 2026
Insilico Medicine will join the HKEX Tech 100 Index on September 14 after changes to the index methodology.
Insilico Medicine will join the HKEX Tech 100 Index on September 14, 2026, the company announced in a press release. The change will be implemented after the market closes on September 11.
The index tracks 100 large Hong Kong listed companies with substantial exposure to technology themes and eligibility for Southbound Stock Connect. Its sectors include artificial intelligence, biotechnology and pharmaceuticals, electric vehicles, information technology, internet services, and robotics.
Insilico Medicine reported about $106 million in revenue for the first half of 2026, up 287% from the same period a year earlier. Its adjusted net profit exceeded $51 million, marking its first profitable half since listing in Hong Kong in December 2025.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
09/03
Superluminal Medicines Raises $60 Million for Obesity Drug Trial
09/03
Unisys Publishes AI Evaluation Framework for Drug Repurposing
09/02
Systech Launches TraceIQ for Pharmaceutical Supply Chains
09/02
Onymos and Vanta Diagnostics Report AI Lab Intake Results
09/02
EpiVax Adds AI Models to ISPRI Immunogenicity Platform
Subscribe to AI Funding Brief
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more